Metraipolis › archive › dc_42cbd36969e2
GLP-1 Receptor Agonists in Breast Cancer: A New Frontier in Obesity and Prognosis Management — Europe PMC PMID:40869064
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40869064
- DOI
- 10.3390/ijms26167744
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T18:03:25.185Z
- SHA-256 of the archived text
94e206aff37ebea19dac7a0a1c77a71af0770b8982998b6b14fad2bc2bf3864b- Stable URL of this page
https://metraipolis.com/documento/dc_42cbd36969e2
How to cite
GLP-1 Receptor Agonists in Breast Cancer: A New Frontier in Obesity and Prognosis Management — Europe PMC PMID:40869064 — Europe PMC (en), https://europepmc.org/article/MED/40869064 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_42cbd36969e2 (Metraipolis archive dc_42cbd36969e2, sha256 94e206aff37ebea19dac7a0a1c77a71af0770b8982998b6b14fad2bc2bf3864b)
BibTeX
@misc{dc42cbd36969e2,
title = {GLP-1 Receptor Agonists in Breast Cancer: A New Frontier in Obesity and Prognosis Management — Europe PMC PMID:40869064},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40869064},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_42cbd36969e2; sha256 94e206aff37ebea19dac7a0a1c77a71af0770b8982998b6b14fad2bc2bf3864b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40869064. Agents can read the archived copy with the MCP tool read_document.